retatrutide clinical trial status Michael Weintraub, MD on X: "Looking forward to when #retatrutide's Phase 3 results will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its Retatrutide for weight loss: Study

In clinical trials, nausea was reported by approximately 29-33% of participants, diarrhea affected 21-23% of patients, constipation occurred in 17-19%, and vomiting in 10-13% of patients

Importantly, Contrave isnt suitable for everyone

Since I had the doctors ear and even though I was not experiencing acute signs nor symptoms of low B12 (pernicious anemia), I took the opportunity to ask him about the possibility of beginning monthly vitamin B12 injections He was aware of my years of nursing practice and thoughtfully considered my request

not for human or veterinary application References Banerjee R., Ragsdale S.W

Long-term Drug Treatment for Obesity: A Systematic and Clinical Review